Vineet Laboratories Limited

VINEETLAB

INE505Y01010

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:54 2024-06-03 am EDT			5-day change	1st Jan Change
58.1 ^INR	+5.54%		-5.37%	-28.84%

May. 30	Vineet Laboratories CEO Resigns	MT
May. 29	Vineet Laboratories Limited Announces Resignation of Satish Pandurang Samant as Executive Director	CI

Vineet Laboratories Limited Announces Resignation of Nirosha Ravikanti as Company Secretary / Compliance Officer of the Company

October 28, 2023 at 08:53 am EDT

Vineet Laboratories Limited informed that Ms. Nirosha Ravikanti, Associate member of the Institute of Company Secretaries of India, having Membership No: A68115, has resigned as Company Secretary and Compliance Officer of the Company with effect from closing business hours of October 28, 2023 due to personal reasons.

Latest news about Vineet Laboratories Limited

Vineet Laboratories CEO Resigns	May. 29	MT
Vineet Laboratories Limited Announces Resignation of Satish Pandurang Samant as Executive Director	May. 29	CI
Vineet Laboratories Limited Announces Resignation of Satish Pandurang Samant as Chief Executive Officer	May. 29	CI
Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Vineet Laboratories Limited Announces Appointment of Mr. Rameshkumar Bandari as Company Secretary and Compliance Officer	Nov. 10	CI
Vineet Laboratories Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 10	CI
Vineet Laboratories Limited Announces Resignation of Nirosha Ravikanti as Company Secretary / Compliance Officer of the Company	23-10-28	CI
Vineet Laboratories Names CEO	23-10-16	MT
Vineet Laboratories Limited Appoints Mr. Satish Pandurang Samant as Chief Executive Officer	23-10-16	CI
Vineet Laboratories Limited Appoints Mr. Satish Pandurang Samant as an Additional Executive Director	23-10-16	CI
Vineet Laboratories Limited Appoints Ranga Raju Alluri as Non-Executive Director	23-09-30	CI
Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-12	CI
Vineet Laboratories Limited Announces Board Changes	23-08-12	CI
Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	23-05-29	CI
Vineet Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-29	CI
Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI

Chart Vineet Laboratories Limited

Duration

Period

More charts

Company Profile

Vineet Laboratories Limited is engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. It also exports API intermediates, fine chemicals, and custom synthesis molecules.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VINEET LABORATORIES LIMITED	-28.84%	6.08M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+31.50%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.51%	240B
NOVARTIS AG	+9.51%	210B
ROCHE HOLDING AG	-5.36%	206B
AMGEN INC.	+6.17%	164B